molecules of the month


allosteric MALT1 protease (paracaspase) inh.

oral QD act. in xenograft; on-target pathology

from 1M cmpd biochem. HTS and opt.

J. Med. Chem., Nov. 20, 2020

Novartis, Basel, CH

Chemical structure of the MLT-985 (Novartis allosteric MALT1 protease inhibitor)
1 min read

MLT-985 (Novartis allosteric MALT1 protease (paracaspase) inhibitor)

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: